Santen Pharmaceuticals ends phaco device development

Phacor Inc., the California-based wholly owned subsidiary of Santen Pharmaceuticals Co. Ltd., ceased operations after 6 years of phacoemulsification system development.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.